Scott N. Wood
300 Herston Road
Brisbane, QLD, Australia
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.
Journal: BMC cancer
Published: March 09, 2026
Explainable machine learning identifies features and thresholds predictive of immunotherapy response.
Journal: Scientific reports
Published: October 17, 2025
Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities.
Journal: Genome medicine
Published: October 11, 2025
Cancer genome standards for long-read sequencing using cancer cell line mixtures.
Journal: GigaScience
Published: May 06, 2025
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.
Journal: Cancer cell
Published: February 07, 2025
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank.
Journal: Frontiers in immunology
Published: May 10, 2023
Circulating Tumor DNA: A Promising Biomarker for Predicting Recurrence in Patients with BRAF-Negative Melanoma.
Journal: The Journal of molecular diagnostics : JMD
Published: April 03, 2023
Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.
Journal: Neuro-oncology
Published: February 09, 2023
The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study.
Journal: Genome medicine
Published: October 04, 2022
Last Updated: 09/26/2026